rs863223540
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001114753.3(ENG):c.1080_1083delGACA(p.Thr361fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,850 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
ENG
NM_001114753.3 frameshift
NM_001114753.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.71
Genes affected
ENG (HGNC:3349): (endoglin) This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds to the beta1 and beta3 peptides with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. This gene may also be involved in preeclampsia and several types of cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-127824354-TTGTC-T is Pathogenic according to our data. Variant chr9-127824354-TTGTC-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 213214.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-127824354-TTGTC-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENG | NM_001114753.3 | c.1080_1083delGACA | p.Thr361fs | frameshift_variant | 8/15 | ENST00000373203.9 | NP_001108225.1 | |
ENG | NM_000118.4 | c.1080_1083delGACA | p.Thr361fs | frameshift_variant | 8/14 | NP_000109.1 | ||
ENG | NM_001278138.2 | c.534_537delGACA | p.Thr179fs | frameshift_variant | 8/15 | NP_001265067.1 | ||
ENG | NM_001406715.1 | c.1080_1083delGACA | p.Thr361fs | frameshift_variant | 8/8 | NP_001393644.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENG | ENST00000373203.9 | c.1080_1083delGACA | p.Thr361fs | frameshift_variant | 8/15 | 1 | NM_001114753.3 | ENSP00000362299.4 | ||
ENG | ENST00000344849.4 | c.1080_1083delGACA | p.Thr361fs | frameshift_variant | 8/14 | 1 | ENSP00000341917.3 | |||
ENG | ENST00000480266.6 | c.534_537delGACA | p.Thr179fs | frameshift_variant | 8/15 | 2 | ENSP00000479015.1 | |||
ENG | ENST00000486329.1 | n.48_51delGACA | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461850Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 727230
GnomAD4 exome
AF:
AC:
1
AN:
1461850
Hom.:
AF XY:
AC XY:
1
AN XY:
727230
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 1 Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Mar 26, 2024 | - - |
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2018 | PVS1+PM2+PP4 - |
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Apr 13, 2021 | The ENG c.1080_1083delGACA; p.Thr361SerfsTer7 variant (rs863223540), also reported as c.1078_1081del, is reported in the literature in multiple individuals affected with hereditary hemorrhagic telangiectasia (HHT) (Gallione 1998, Nishida 2012, Snellings 2019). This variant is also reported in ClinVar (Variation ID: 213214). This variant is absent from the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by deleting four nucleotides, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Gallione CJ et al. Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat. 1998;11(4):286-94. Nishida T et al. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. Am J Med Genet A. 2012 Nov;158A(11):2829-34. Snellings DA et al. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1. Am J Hum Genet. 2019 Nov 7;105(5):894-906. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 24, 2018 | The c.1080_1083delGACA pathogenic variant in the ENG gene, also reported as c.1078_1081delGACA due to alternate nomenclature, has been identified previously in multiple members of a large family with HHT (Gallione et al., 1998). It has also been identified in several other unrelated individuals with HHT (Wehner et al., 2006; Bossler wt al., 2006; Olivieri et al., 2007; Nishida et al., 2012). Additionally, the c.1080_1083delGACA variant has not been observed in large population cohorts (Lek et al., 2016). The c.1080_1083delGACA variant causes a shift in reading frame starting at codon threonine 361, changing it to a serine, and creating a premature stop codon at position 7 of the new reading frame, denoted p.Thr361SerfsX7. This pathogenic variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Furthermore, other frameshift variants in the ENG gene have been reported in Human Gene Mutation Database in association with HHT (Stenson et al., 2014), indicating that loss of function is a mechanism of disease for this gene. - |
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 24, 2020 | PVS1, PS4, PP1_Strong, PM2, PP4 - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2022 | The c.1080_1083delGACA pathogenic mutation, located in coding exon 8 of the ENG gene, results from a deletion of 4 nucleotides at nucleotide positions 1080 to 1083, causing a translational frameshift with a predicted alternate stop codon (p.T361Sfs*7). This mutation has been identified in multiple individuals with epistaxis, telangiectasias, and pulmonary arteriovenous malformations (Gallione CJ et al. Hum. Mutat., 1998;11:286-94; Wehner LE et al. Clin. Genet., 2006 Mar;69:239-45; Lee NP et al. J. Med. Genet., 2011 May;48:353-7). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In addition, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Hereditary hemorrhagic telangiectasia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2023 | This premature translational stop signal has been observed in individual(s) with hereditary hemorrhagic telangiectasia (PMID: 9554745, 16542389, 17786384, 21158752, 22991266). ClinVar contains an entry for this variant (Variation ID: 213214). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr361Serfs*7) in the ENG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ENG are known to be pathogenic (PMID: 15879500). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at